Audrey Holtzinger, PhD

Evotec, Germany

Presentation(s):

• STRATEGIES FOR THE DEVELOPMENT OF ALLOGENIC iPSC-DERIVED CELL THERAPIES

  Thursday, July 11, 2024
  8:15 AM – 9:45 AM CEST